This research project was conducted in the frame of identifying the possibility of Danirixin use as a future treatment for ileus by proving the direct effect of danirixin on smooth muscle cell function through its signalling as a CXCR2 antagonist and investigating the effects of danirixin treatment on the overall proliferation and differentiation of the human smooth muscle cells.